Curis, Inc. (NASDAQ: CRIS) – brief chart analysis for you – lots of room to grow Play on your own risk. About Curis, Inc. Curis, Inc., (NASDAQ: CRIS) a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company develops CUDC-907, […]
by BiotechIll Guest Author Cell Therapeutics, Inc. (CTIC) today announced that its paclitaxel poliglumex drug OPAXIO has been granted orphan-drug designation by the U. S Food and Drug Administration for the treatment of malignant brain cancer (glioblastoma multiforme). CTIC stock closed up 11.2% on the 4fold of its 10day average volume. Phase 2 study has […]
by MisterQ Guest Author Dehaier Medical Systems Ltd. (DHRM) stock gained over 15% on Friday’s trading session within almost a million shares in volume after company’s announcement of a two-year exclusive distribution agreement with GCE group for GCE’s EASE II products in Mainland China. EASE II device is an automatically triggered high-flow oxygen device, which […]
by MisterQ Guest Author LodgeNet Interactive Corporation (LNET) stock today traded 1/7th of its float despite of the public announcement that Mr. Mark Cuban, #188 in Forbes List for United States, owner of Dallas Mavericks & beneficial owner of more than 6% of the LodgeNet (lol), sold on open market ~700K LNET shares since the […]
DARA BioSciences, Inc. (DARA) announced today that company entered into an exclusive agreement with The Helsinn Group of Switzerland for U.S. commercial rights to Gelclair®. DARA plans to launch Gelclair, FDA-cleared product indicated for the treatment of oral mucositis, in the first quarter of 2013. Oral mucositis market is approximately 400,000 patients annually according to […]
By Mr. BiotechIll, Guest Author Shares of Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) gain almost half their value after announcement that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial in patients with refractory non-small cell lung cancer (NSCLC). At glance: Data show statistically significant improvement in overall survival for patients receiving […]
Genetic Technologies (GENE) seeks a royalty, interest and costs from the Reproductive Genetics Institute of Australia for infringes its Patent #5,612,179 “Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes”. Company filed court documents on August 27th. We alerted our “A” list subscribers on this trading opportunity in the morning. […]
Aeterna Zentaris Inc. (NASDAQ: AEZS) announced on June 28th that its Japanese partner Yakult Honsha (“Yakult”) (Tokyo: 2267) has initiated a Phase 1 trial in multiple myeloma, a form of blood cancer, with perifosine, the Company’s oral Akt/PI3K inhibitor drug. Yakult, who are sponsoring and conducting this trial in Japan, reported that a first patient […]
JA Solar Holdings Co., Ltd. (JASO) today announced that its board of directors has approved a share repurchase program, effective immediately, that authorizes JA Solar to repurchase up to a US$100 million worth of its issued and outstanding American Depositary Shares (“ADSs”) prior to September 30, 2012. This repurchase program is about of 50% of […]
A123 Systems (AONE) today introduced Nanophosphate EXT(TM), a new lithium ion battery technology capable of operating at extreme temperatures without requiring thermal management. Nanophosphate EXT is designed to significantly reduce or eliminate the need for heating or cooling systems, which is expected to create sizeable new opportunities within the transportation and telecommunications markets, among others. […]
